Product. The SPONSOR undertakes to provide through the Pharmacy Department (in the case of clinical trials with drugs) or the Supplies Department (in the case of medical devices), the products for the conduction of the Trial, with no cost for the site as provided in article 39 of Royal Decree 1090/2015; in exceptional circumstances and after written consent is obtained, other routes of supply and financing may be used. Said product may not be used, marketed or supplied to any third party without prior written consent by the SPONSOR. In the event that after the conduction of the Trial there is product left over, the INVESTIGATOR and the Site shall be bound to promptly return it to the SPONSOR. For this purpose, the Site shall take the necessary measures for such restitution. After the completion of the Clinical Trial, the Sponsor shall agree with the Site on the withdrawal, destruction or transfer procedures of the surplus product (if they are marketed products), in accordance with Chapter II of Royal Decree 1015/2009, regulating the availability of drugs in special conditions.
Product. Any Merck drug/medicinal product, biological product, medical device or
Product. Any Merck drug/medicinal product, biological product, medical device or food supplement (irrespective or patent status and/or whether it is branded or not).